Watchlist Price Alert

X4 Pharmaceuticals Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

2.94

0.21 (7.69%)

At close: Jun 17, 2025, 10:47 AM

X4 Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	55.7M	99.22M	121.72M	81.79M	78.71M	126.18M	30.75M	76.79M	3.04M
Short-Term Investments	46.36M	15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.02M	1.32M	1.73M	1.9M	364K	355K	394K
Other Long-Term Assets	2.08M	1.44M	1.23M	1.72M	3.26M	1.95M	275K	-355K	975K
Receivables	1.71M	562K	1.15M	747K	917K	2M	2.86M	1.61M	1.34M
Inventory	2.82M	n/a	n/a	n/a	n/a	n/a	n/a	355K	1.25M
Other Current Assets	5.59M	7.3M	5.81M	n/a	n/a	n/a	101K	n/a	n/a
Total Current Assets	112.17M	122.08M	128.68M	87.88M	83.31M	129.28M	35.08M	80.83M	5.72M
Property-Plant & Equipment	4.84M	6.39M	8.33M	10.22M	9.2M	2.36M	285K	421K	519K
Goodwill & Intangibles	27.35M	17.35M	17.35M	17.35M	27.11M	27.11M	n/a	n/a	n/a
Total Long-Term Assets	34.27M	25.18M	26.91M	29.3M	39.56M	31.42M	924K	421K	1.89M
Total Assets	146.45M	147.26M	155.59M	117.18M	122.87M	160.7M	36M	81.25M	7.6M
Account Payables	8.62M	8.95M	7.78M	4.28M	3.14M	2.09M	545K	1.89M	1.65M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	737K	2.63M	504K
Short-Term Debt	n/a	n/a	2.51M	1.87M	786K	898K	1.69M	2.31M	5.13M
Other Current Liabilities	14.3M	8.2M	5.39M	4.34M	3.48M	2.65M	1.5M	3.33M	3.48M
Total Current Liabilities	32.88M	22.86M	22.32M	14.02M	11.95M	9.45M	5.4M	7.68M	12.06M
Long-Term Debt	75.42M	54.57M	32.3M	33.14M	33.18M	20.1M	7.89M	9.92M	10.13M
Other Long-Term Liabilities	14.59M	16.11M	23.3M	826K	462K	16K	5K	9K	-39.75M
Total Long-Term Liabilities	91.42M	73.3M	59.21M	38.74M	38.12M	22.03M	9.01M	14.87M	52.11M
Total Liabilities	124.3M	96.16M	81.53M	52.76M	50.07M	31.48M	14.4M	22.55M	64.17M
Total Debt	78.09M	58.28M	38.42M	39.78M	38.45M	22.91M	7.89M	12.24M	15.29M
Common Stock	171K	167K	122K	28K	16K	16K	15K	15K	1K
Retained Earnings	-515.36M	-477.9M	-376.74M	-282.87M	-194.18M	-132.04M	-135.29M	-92.27M	-58.39M
Comprehensive Income	-122K	-119K	-119K	-119K	-119K	-119K	241K	127K	834K
Shareholders Equity	22.15M	51.1M	74.05M	64.41M	72.8M	129.22M	21.6M	58.71M	-56.56M
Total Investments	46.36M	15M	1.02M	1.32M	1.73M	1.9M	364K	355K	394K